Comparability of Beckman Coulter Cardiac Troponin I Assays

Caroline G Stanek1, Jose Lima1, Liyun Cao2

  • 1Department of Pathology, The University of Alabama at Birmingham, Birmingham AL, USA.

Insights

Beckman Coulter cardiac troponin I (cTnI) assays show comparable results when used on the same instrument, but differences arise between contemporary and high-sensitivity assays, especially at lower levels. Reporting the specific assay and instrument is recommended for accurate interpretation.

Area of Science:

  • Clinical Chemistry
  • Biomarker Analysis
  • Cardiovascular Diagnostics

Background:

  • Cardiac troponin I (cTnI) is a critical biomarker for diagnosing myocardial injury, with changes above the 99th percentile of the upper reference limit (URL) essential for acute myocardial infarction assessment.
  • Accurate measurement of cTnI is vital for timely and correct patient management.

Purpose of the Study:

  • To evaluate the analytical performance and concordance between the Beckman Coulter contemporary cTnI AccuTnI+3 assay and the high-sensitivity cTnI (hs-cTnI) assay.
  • To assess the agreement of hs-cTnI results across different Beckman Coulter instruments (DXI 800 and Access 2).

Main Methods:

  • Analyzed 424 patient specimens using the AccuTnI+3 and hs-cTnI assays on the DXI 800 instrument.
  • Compared hs-cTnI results from the Access 2 and DXI 800 instruments using 115 patient specimens.

Main Results:

  • Between-method comparison on DXI 800 showed good correlation (CC=0.9590) but significant bias (-5.16%) at levels below 20 ng/L.
  • Within-method comparison of hs-cTnI on Access 2 and DXI 800 demonstrated high concordance (CC=0.9915) overall.
  • hs-cTnI results were more comparable between instruments at levels below 200 ng/L (CC=0.9951).

Conclusions:

  • Contemporary AccuTnI+3 and hs-cTnI assays yield comparable results on the DXI 800, particularly above the 99th percentile URL.
  • hs-cTnI results are comparable between Access 2 and DXI 800 instruments, especially at concentrations below 200 ng/L.
  • Laboratories should report the specific cardiac troponin assay and instrument used to prevent misinterpretation of results.
Abstract